Dr. Reddy's Laboratories Gestione
Gestione criteri di controllo 2/4
Dr. Reddy's Laboratories Il CEO è Erez Israeli, nominato in Apr2018, ha un mandato di 6.58 anni. possiede direttamente 0.007% delle azioni della società, per un valore di ₹ 65.07M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 6.6 anni e 2.8 anni.
Informazioni chiave
Erez Israeli
Amministratore delegato
₹197.1m
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 6.6yrs |
| Proprietà del CEO | 0.007% |
| Durata media del management | 6.6yrs |
| Durata media del Consiglio di amministrazione | 2.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Are Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Investors Paying Above The Intrinsic Value?
Nov 23
Dr. Reddy's Laboratories Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next
Nov 08Insufficient Growth At Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Hampers Share Price
Nov 01Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Oct 14If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Aug 19Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
Aug 01The Market Doesn't Like What It Sees From Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Earnings Yet
Jul 30Dr. Reddy's Laboratories (NSE:DRREDDY) Seems To Use Debt Rather Sparingly
Jul 12Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
Jun 23Additional Considerations Required While Assessing Dr. Reddy's Laboratories' (NSE:DRREDDY) Strong Earnings
Jun 20Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Dividend Of ₹40.00
May 26Dr. Reddy's Laboratories (NSE:DRREDDY) Will Pay A Dividend Of ₹40.00
May 10With EPS Growth And More, Dr. Reddy's Laboratories (NSE:DRREDDY) Makes An Interesting Case
May 06There Is A Reason Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Price Is Undemanding
Apr 18Earnings Beat: Dr. Reddy's Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 02Should You Be Adding Dr. Reddy's Laboratories (NSE:DRREDDY) To Your Watchlist Today?
Jan 19Why Investors Shouldn't Be Surprised By Dr. Reddy's Laboratories Limited's (NSE:DRREDDY) Low P/E
Jan 01Dr. Reddy's Laboratories (NSE:DRREDDY) Has A Rock Solid Balance Sheet
Oct 21If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Oct 03Dr. Reddy's Laboratories (NSE:DRREDDY) Could Easily Take On More Debt
Jul 14Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
Jun 24Dr. Reddy's Laboratories (NSE:DRREDDY) Is Paying Out A Larger Dividend Than Last Year
Jun 10Dr. Reddy's Laboratories (NSE:DRREDDY) Is Increasing Its Dividend To ₹40.00
May 27Dr. Reddy's Laboratories' (NSE:DRREDDY) Dividend Will Be Increased To ₹40.00
May 13Is Dr. Reddy's Laboratories (NSE:DRREDDY) Using Too Much Debt?
Apr 11If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Mar 06These 4 Measures Indicate That Dr. Reddy's Laboratories (NSE:DRREDDY) Is Using Debt Reasonably Well
Jan 10If EPS Growth Is Important To You, Dr. Reddy's Laboratories (NSE:DRREDDY) Presents An Opportunity
Dec 05Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹53b |
| Jun 30 2024 | n/a | n/a | ₹56b |
| Mar 31 2024 | ₹197m | n/a | ₹56b |
| Dec 31 2023 | n/a | n/a | ₹52b |
| Sep 30 2023 | n/a | n/a | ₹51b |
| Jun 30 2023 | n/a | n/a | ₹47b |
| Mar 31 2023 | ₹195m | n/a | ₹45b |
| Dec 31 2022 | n/a | n/a | ₹36b |
| Sep 30 2022 | n/a | n/a | ₹31b |
| Jun 30 2022 | n/a | n/a | ₹30b |
| Mar 31 2022 | ₹127m | n/a | ₹24b |
| Dec 31 2021 | n/a | n/a | ₹26b |
| Sep 30 2021 | n/a | n/a | ₹19b |
| Jun 30 2021 | n/a | n/a | ₹17b |
| Mar 31 2021 | ₹120m | n/a | ₹17b |
| Dec 31 2020 | n/a | n/a | ₹21b |
| Sep 30 2020 | n/a | n/a | ₹15b |
| Jun 30 2020 | n/a | n/a | ₹19b |
| Mar 31 2020 | ₹195m | ₹107m | ₹19b |
| Dec 31 2019 | n/a | n/a | ₹16b |
| Sep 30 2019 | n/a | n/a | ₹27b |
| Jun 30 2019 | n/a | n/a | ₹21b |
| Mar 31 2019 | ₹123m | n/a | ₹19b |
Compensazione vs Mercato: La retribuzione totale di Erez ($USD 2.33M ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 1.08M ).
Compensazione vs guadagni: La retribuzione di Erez è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Erez Israeli (56 yo)
6.6yrs
Mandato
₹197,090,000
Compensazione
Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019 and has been its Member of the Management Council since April 02, 2018. Mr. Israeli served as...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Chairman | 38.6yrs | ₹186.28m | 13.07% ₹ 129.9b | |
| Chairman of the Board & Member of the Management Council | 31.8yrs | ₹116.17m | 13.61% ₹ 135.2b | |
| CEO & Member of the Management Council | 6.6yrs | ₹197.09m | 0.0066% ₹ 65.1m | |
| CFO & Member of the Management Council | less than a year | ₹48.82m | 0.0057% ₹ 56.3m | |
| Global Head of Quality and Pharmacovigilance & Member of the Management Council | less than a year | ₹6.15m | Nessun dato | |
| CEO of API & Services & Member of Management Council | no data | ₹41.90m | 0.0027% ₹ 26.6m | |
| CEO of Branded Markets - India & Emerging Countries and Member of Management Council | no data | ₹82.74m | 0.016% ₹ 156.3m | |
| EVP, Head of Corporate Communications | 7.4yrs | ₹65.21m | 0.0063% ₹ 63.1m | |
| Executive VP | 7.3yrs | ₹66.05m | Nessun dato | |
| CEO of European Generics & Member of Management Council | no data | ₹63.09m | Nessun dato | |
| Global Head of Integrated Product Development Organisation & Member of the Management Council | no data | ₹55.63m | 0.000020% ₹ 198.7k | |
| Global Head – Biologics & Member of the Management Council | no data | ₹34.59m | Nessun dato |
6.6yrs
Durata media
56yo
Età media
Gestione esperta: Il team dirigenziale di DRREDDY è esperto e expertise (durata media dell'incarico 6.6 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Chairman | 38.6yrs | ₹186.28m | 13.07% ₹ 129.9b | |
| Chairman of the Board & Member of the Management Council | 31.8yrs | ₹116.17m | 13.61% ₹ 135.2b | |
| Member of the Scientific Advisory Board | no data | ₹8.36m | Nessun dato | |
| Independent Director | 2.3yrs | ₹18.77m | Nessun dato | |
| Independent Director | 5.8yrs | ₹13.34m | Nessun dato | |
| Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Lead Independent Director | 6.1yrs | ₹17.10m | Nessun dato | |
| Independent Director | 2.8yrs | ₹14.18m | Nessun dato | |
| Independent Director | less than a year | ₹3.32m | Nessun dato | |
| Independent Director | 1.8yrs | ₹8.25m | Nessun dato | |
| Independent Director | 2.8yrs | ₹17.10m | Nessun dato | |
| Independent Director | 1.5yrs | ₹16.09m | Nessun dato |
2.8yrs
Durata media
64yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di DRREDDY non è considerato esperto (durata media del mandato 2.8 anni), il che suggerisce un nuovo consiglio.